425: Strive & Semler Scientific Merger Update

Strive, Inc. filed a Form 425 regarding its proposed business combination with Semler Scientific, Inc., including cautionary statements and details on where to find further information.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• Strive filed a Form 425, and an investor presentation was posted on November 10, 2025, in connection with the proposed merger.
• The filing emphasizes that statements regarding the transaction, strategic benefits, financial performance, timing, and integration are forward-looking and subject to significant risks and uncertainties.
• A Registration Statement on Form S-4 has been filed by Strive to register the Class A common stock to be issued, which includes an Information Statement/Proxy Statement/Prospectus for Semler Scientific stockholders' approval.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus, along with other relevant documents filed with the SEC, for important information about the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is primarily procedural and cautionary, outlining risks associated with a proposed business combination. It does not present new financial results or operational updates, maintaining a neutral tone focused on regulatory compliance and investor awareness of forward-looking statement limitations.

Risks

• The merger agreement could be terminated by either Strive or Semler Scientific.
• The proposed transaction may not close as expected or at all if the conditions to closing are not received or satisfied on a timely basis.
• Potential legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized as expected, partly due to changes in or problems arising from Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution for existing Strive shareholders caused by the issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before the closing of the transaction.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing contains general forward-looking statements regarding the outlook and expectations for the proposed transaction, including anticipated strategic and financial benefits, timing of closing, and successful integration. However, it explicitly cautions that these statements are subject to significant risks and uncertainties and may not be realized, urging investors not to rely too heavily on them.

Industry Context

This filing is a procedural step in a proposed business combination, a common strategic move for companies seeking growth, market consolidation, or diversification. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests a potential strategic pivot or integration of digital asset management, reflecting a growing trend in certain sectors to engage with the digital economy or diversify treasury holdings.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company could impact the proposed transaction or future results.

Stakeholder Impact

• Potential adverse reactions from Strive's or Semler Scientific's customers due to the proposed transaction.
• Changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Dilution for Strive's Class A common stock shareholders due to the issuance of additional shares in connection with the merger.

Next Steps

• Strive and Semler Scientific will continue to work towards satisfying the conditions for closing the proposed transaction.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors are urged to read the Registration Statement on Form S-4 and other relevant documents filed with the SEC when they become available.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Business Combination, SEC Filing, Form 425, Corporate Governance, Risk Factors, Forward-Looking Statements, Bitcoin Treasury, Digital Assets